Green Fresh Biotechnology Company Limited
Research Green Fresh Biotechnology Company Limited (1084.HK) on Bullrun: market cap HKD 546.28M, P/E 31.5, dividend yield 1.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1084.HK
- ExchangeHK
- CountryHong Kong
- SectorConsumer Defensive
- IndustryFarm Products
- CurrencyHKD
- Market capHKD 546.28M
- P/E31.5
- Dividend yield1.9%
- Financial periodFY2025
- RevenueCNY 904.69M
- Revenue growth-8.5%
- Net incomeCNY 6.59M
- Free cash flow-CNY 19.12M
- Gross margin18.5%
Valuation Snapshot
latest market cap is HKD 546.28M; P/E is 31.5; dividend yield is 1.9%.
Peer valuation comparison
Latest P/E is 31.5x versus a Consumer Defensive sector median of 16.8x (87.5% above).
Latest dividend yield is 1.9% versus a Consumer Defensive sector median of 2.92% (34.9% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 904.69M | CNY 6.59M | -CNY 19.12M | 18.5% | n/a | CNY 88.64M | CNY 592.85M | CNY 838.69M |
| FY2024 | CNY 989.26M | CNY 62.17M | CNY 80.72M | 22.5% | 0.07 | CNY 120.73M | CNY 565.13M | CNY 839.87M |
| FY2023 | CNY 1.17B | -CNY 85.33M | CNY 84.75M | 3.2% | -0.1 | CNY 72.60M | CNY 601.97M | CNY 745.24M |
| FY2022 | CNY 1.41B | CNY 199.23M | -CNY 69.62M | 27.2% | 0.24 | CNY 37.68M | CNY 584.34M | CNY 844.64M |
| FY2021 | n/a | n/a | n/a | n/a | 0.1 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 546.28M | 31.5 | 1.9% | 0.01 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.01 HKD, yield 1.9%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.01 CNY |
| FY2023 | 0.03 CNY |
| FY2022 | 0.05 CNY |
| FY2021 | 0.04 CNY |
About Green Fresh Biotechnology Company Limited
Green Fresh Biotechnology Company Limited, an investment holding company, engages in the production of seaweed-based and plant-based hydrocolloid products in the Mainland China, Europe, rest of Asia, South America, North America, Africa, and Oceania. The company operates through five segments: Manufacturing and Sales of Agar-Agar; Manufacturing and Sales of Carrageenan; Manufacturing and Sales of Konjac Products; Manufacturing and Sales of Blended Products; and Others.
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Green Fresh Biotechnology Company Limited's market cap?
Green Fresh Biotechnology Company Limited's market capitalization is HKD 546.28M.
What is Green Fresh Biotechnology Company Limited's P/E ratio?
Green Fresh Biotechnology Company Limited's price-to-earnings (P/E) ratio is 31.5.
Does Green Fresh Biotechnology Company Limited pay a dividend?
Green Fresh Biotechnology Company Limited has a dividend yield of 1.9%.
What does Green Fresh Biotechnology Company Limited do?
Green Fresh Biotechnology Company Limited, an investment holding company, engages in the production of seaweed-based and plant-based hydrocolloid products in the Mainland China, Europe, rest of Asia, South America, North America, Africa, and Oceania. The company operates through five segments: Manufacturing and Sales of Agar-Agar; Manufacturing and Sales of Carrageenan; Manufacturing and Sales of Konjac Products; Manufacturing and Sales of Blended Products; and Others.